Suppression of HIV production in resting lymphocytes by combining didanosine and hydroxamate compounds.
Malley
S D
SD
Grange
J M
JM
Hamedi-Sangsari
F
F
Vila
J R
JR
D002455:Cell Division / Q000187:drug effects; D003588:Cytopathogenic Effect, Viral / Q000187:drug effects; D016049:Didanosine / Q000494:pharmacology*; D004357:Drug Synergism; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D007399:Interphase / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects / Q000382:microbiology*; D014779:Virus Replication / Q000187:drug effects; D016047:Zalcitabine / Q000494:pharmacology*; D015215:Zidovudine / Q000494:pharmacology*
D015215:Zidovudine; D016047:Zalcitabine; D016049:Didanosine